Depletion of microglia and inhibition of exosome synthesis halt tau propagation

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Neuroscience

• Publication date

  2015-10-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nn.4132PMID 26436904PMCID PMC4694577
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice

  2015cited by this paper
• Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer’s disease or corticobasal degeneration brains

  2015cited by this paper
• Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study

  2015cited by this paper
• Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.

  2015cited by this paper
• Prion strains are differentially released through the exosomal pathway

  2015cited by this paper
• A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity

  2014cited by this paper
• Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease

  2014cited by this paper
• Microglial phagocytosis of live neurons

  2014cited by this paper
• Distinct tau prion strains propagate in cells and mice and define different tauopathies.

  2014cited by this paper
• Neuronal activity regulates extracellular tau in vivo

  2014cited by this paper
• Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles

  2014cited by this paper
• Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer’s disease

  2014cited by this paper
• Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain.

  2014cited by this paper
• BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

  2013cited by this paper
• Integrated Expression Profiles of mRNA and miRNA in Polarized Primary Murine Microglia

  2013cited by this paper
• Extracellular vesicles: biology and emerging therapeutic opportunities

  2013cited by this paper
• Brain homogenates from human tauopathies induce tau inclusions in mouse brain

  2013cited by this paper
• Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy

  2013cited by this paper
• Identification of a Unique TGF-β Dependent Molecular and Functional Signature in Microglia

  2013cited by this paper
• Multiplex Genetic Fate Mapping Reveals a Novel Route of Neocortical Neurogenesis, Which Is Altered in the Ts65Dn Mouse Model of Down Syndrome

  2013cited by this paper
• Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner.

  2012cited by this paper
• Propagation of tau pathology in a model of early Alzheimer's disease.

  2012cited by this paper
• Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits

  2012cited by this paper
• Exosomal cell-to-cell transmission of alpha synuclein oligomers

  2012cited by this paper
• Trans-Synaptic Spread of Tau Pathology In Vivo

  2012cited by this paper
• MFG-E8 Mediates Primary Phagocytosis of Viable Neurons during Neuroinflammation

  2012cited by this paper
• Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease

  2012cited by this paper
• Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

  2012cited by this paper
• Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

  2012cited by this paper
• Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex

  2012cited by this paper
• Biochemical and Biologic Characterization of Exosomes and Microvesicles as Facilitators of HIV-1 Infection in Macrophages

  2012cited by this paper
• Tau Oligomers Impair Artificial Membrane Integrity and Cellular Viability*

  2012cited by this paper
• The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular Space*

  2012cited by this paper
• S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain

  2011cited by this paper
• Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission

  2011cited by this paper
• Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain

  2011cited by this paper
• FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders

  2011cited by this paper
• AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice

  2011cited by this paper
• Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease*

  2011cited by this paper
• Phagocytic activity of neuronal progenitors regulates adult neurogenesis

  2011cited by this paper
• Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease.

  2011cited by this paper
• Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models.

  2010cited by this paper
• Inhibition of neutral sphingomyelinase‐2 perturbs brain sphingolipid balance and spatial memory in mice

  2010cited by this paper
• Transmission and spreading of tauopathy in transgenic mouse brain

  2009cited by this paper
• CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction

  2009cited by this paper
• Membrane vesicles as conveyors of immune responses

  2009cited by this paper
• Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes

  2008cited by this paper
• Debris clearance by microglia: an essential link between degeneration and regeneration

  2008cited by this paper
• Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.

  2007cited by this paper
• Kinetic Analysis of Aggregated Amyloid-β Peptide Clearance in Adult Bone-marrow-derived Macrophages from APP and CCL2 Transgenic Mice

  2007cited by this paper
• Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1

  2007cited by this paper
• Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids

  2006cited by this paper
• Promoters and serotypes: targeting of adeno‐associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo

  2005cited by this paper
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

  2005cited by this paper
• Infectious disease: Unravelling SARS lethality

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.

  2003cited by this paper
• Tau‐66: evidence for a novel tau conformation in Alzheimer's disease

  2001cited by this paper
• Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

  2000cited by this paper
• An olfactory sensory map in the fly brain.

  2000cited by this paper
• Cerebral Amyloid Induces Aberrant Axonal Sprouting and Ectopic Terminal Formation in Amyloid Precursor Protein Transgenic Mice

  1999cited by this paper
• Alz‐50 and MC‐1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau

  1997cited by this paper
• Monoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404

  1994cited by this paper
• Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus.

  1990cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• The impact of CSF1R inhibitor-mediated microglial depletion in rodent models of Alzheimer’s and Parkinson’s disease: a systematic review and meta-analysis

  2026cites this paper
• Exosomal bioactive molecules: molecular regulation, functional heterogeneity, and translational implications in disease diagnostics and therapeutics.

  2026cites this paper
• Immunometabolism Reframes Alzheimer’s Disease: From Systemic Dysmetabolism to Glial Rewiring

  2026cites this paper
• Targeting tau in Alzheimer's Disease: rationale, approach and challenges.

  2026cites this paper
• Exosomal crosstalk between breast cancer cells and tumor-associated macrophages: mechanisms and therapeutic implications

  2026cites this paper
• The glymphatic system as a brain scavenger in Alzheimer's disease: mechanisms and therapeutic implications.

  2026cites this paper
• Extracellular Vesicles in Tauopathies: Mechanisms and Applications.

  2026cites this paper
• Sleep disturbances and Alzheimer's disease: a multiscale approach from exposome to neurobiology and precision medicine.

  2026cites this paper
• Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation

  2026cites this paper
• Advances in Alzheimer's disease: mechanistic insights and therapeutic targets.

  2026cites this paper
• Neuroinflammation as a driver of Down syndrome-associated Alzheimer's disease.

  2026cites this paper
• Elucidation of Molecular Mechanisms of Lipid-Altered Cytotoxicity of TDP-43 Fibrils.

  2026cites this paper
• Dynamics and Impact of Repopulating Microglia Following Oligodendroglial Damage

  2026cites this paper
• Role Shift of Glial Cells from Physiology to Pathology in Alzheimer's Disease: The Regulatory Impact of Exercise.

  2026cites this paper
• Alzheimer's disease as a systems-level timing disorder: Circadian disruption of glial immunometabolism, brain clearance, and therapeutic responsiveness

  2026cites this paper
• Current progress in pathway-targeted therapeutics for Alzheimer's disease: mechanistic insights and windows of opportunity.

  2026cites this paper
• Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer’s disease

  2026cites this paper
• The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's disease.

  2026cites this paper
• Advances in Immune Cell Interactions and Natural Compounds Therapeutic Strategies in Alzheimer's Disease.

  2026cites this paper
• Phytomicronutrients in neurodegeneration: modulating microglial dynamics for neuroprotection

  2026cites this paper
• Biophysically realistic network-level transport model of tau progression with exosome-mediated release and uptake processes

  2026cites this paper
• Small EVs miRNA profiles and their expressions in EVs-depleted plasma as an optimal combination panel for treatment-resistant schizophrenia.

  2026cites this paper
• Impact of Sex and Glial Tau Expression on Heat Shock Protein Induction in a Drosophila Model of Tauopathy

  2025cites this paper
• Glial phagocytosis for synapse and toxic proteins in neurodegenerative diseases

  2025influential citation
• The Role of Extracellular Vesicles in Brain‐Peripheral Communication Following Ischemic Stroke: Implications for Neural Repair and Regeneration

  2025cites this paper
• Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau

  2025cites this paper
• The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway.

  2025cites this paper
• The APOE–Microglia Axis in Alzheimer’s Disease: Functional Divergence and Therapeutic Perspectives—A Narrative Review

  2025cites this paper
• P2RX7 regulates tauopathy progression via tau and mitochondria loading in extracellular vesicles

  2025cites this paper
• The Therapeutic Potential of Butyrate and Lauric Acid in Modulating Glial and Neuronal Activity in Alzheimer’s Disease

  2025cites this paper
• Potential common pathogenesis of several neurodegenerative diseases

  2025cites this paper
• Microglia energy metabolism: A new perspective on Alzheimer's disease treatment.

  2025cites this paper
• Exploring microglial replacement: From disease models to clinical translation.

  2025cites this paper
• Role of astroglia and microglia in Alzheimer's disease and multiple therapeutic interventions

  2025cites this paper
• Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential

  2025cites this paper
• [Effect of removing microglia from spinal cord on nerve repair after spinal cord injury in mice].

  2025cites this paper
• Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2

  2025cites this paper
• Small HSPs at the crossroad between protein aggregation, autophagy and unconventional secretion: clinical implications and potential therapeutic opportunities in the context of neurodegenerative diseases

  2025cites this paper
• The Complementary Role of Morphology in Understanding Microglial Functional Heterogeneity

  2025influential citation
• Niche-specific therapeutic targeting of myeloid cells in the central nervous system.

  2025cites this paper
• Exosomes and their roles in major depressive disorder: an overview of the research progress and perspectives

  2025cites this paper
• Chaihu-Shugan-San Alleviates Post-Stroke Depression in Mice: Mechanistic Insights into Exosome-Mediated Neuroprotection.

  2025cites this paper
• Inhibition of acid or neutral sphingomyelinases differentially impacts RNA and protein cargo sorting to extracellular vesicles

  2025cites this paper
• Whispers in the Brain: Extracellular Vesicles in Neuropathology and the Diagnostic Alchemy of Neurological Diseases

  2025cites this paper
• P-glycoprotein and Alzheimer’s Disease: Threats and Opportunities

  2025cites this paper
• A multimodal approach of microglial CSF1R inhibition and GENUS provides therapeutic effects in Alzheimer’s disease mice

  2025cites this paper
• High Affinity Staining for Histological Immunoreactivity revealed phosphorylated tau within amyloid-cored plaques in the brain of AD model mice.

  2025cites this paper
• Reciprocal Interactions Between Periodontal Disease and Alzheimer’s Disease: Implications for Mutual Triggering, Exacerbation, and Treatment Interventions—A Comprehensive Review of the Literature

  2025cites this paper
• Comprehensive account of exosome isolation from rat substantia nigra for mass spectrometry-based proteomics study.

  2025cites this paper
• Sex specific correction of maternal inflammation-induced behavioral abnormalities by the inhibition of colony-stimulating factor 1 receptor

  2025cites this paper
• Neuron‐Derived Extracellular Vesicles: Emerging Biomarkers and Functional Mediators in Alzheimer's Disease, With Comparative Insights Into Neurodevelopment and Aging

  2025cites this paper
• Aging on Chip: Harnessing the Potential of Microfluidic Technologies in Aging and Rejuvenation Research

  2025cites this paper
• Long-term Nrf2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy

  2025cites this paper
• Astrocyte-driven vasoconstriction impairs glymphatic clearance in a human tauopathy-on-chip model

  2025cites this paper
• NEU1-Mediated Extracellular Vesicle Glycosylation in Alzheimer’s Disease: Mechanistic Insights into Intercellular Communication and Therapeutic Targeting

  2025influential citation
• Granzyme K+ CD8 T cells slow tauopathy progression by targeting microglia

  2025cites this paper
• Depression exacerbates AD pathology through lactate-dependent activation of microglial Kv1.3 to promote Aβ-containing exosome spreading

  2025cites this paper
• An Alzheimer’s disease-associated common regulatory variant in a PTK2B intron alters microglial function

  2025cites this paper
• Microglia-neuron crosstalk in Alzheimer's disease: an exploration of molecular mechanisms and pathological implications.

  2025cites this paper
• Targeting Inflammation in Alzheimer’s Disease: Insights Into Pathophysiology and Therapeutic Avenues-A Comprehensive Review

  2025cites this paper
• Peripheral administration of blood from tau transgenic animals exacerbates brain tau-associated pathology

  2025cites this paper
• Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease

  2025cites this paper
• Circular RNAs, miRNAs, and Exosomes: Their Roles and Importance in Amyloid-Beta and Tau Pathologies in Alzheimer's Disease

  2025cites this paper
• Refining the interactions between microglia and astrocytes in Alzheimer's disease pathology.

  2025cites this paper
• Exploring human brain development and disease using assembloids.

  2025cites this paper
• Advancing Alzheimer's disease therapy through engineered exosomal Macromolecules.

  2025cites this paper
• GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau

  2025cites this paper
• A review of the role of tumor-derived exosomes in cancers treatment and progression.

  2025cites this paper
• The role of microglia in the prion-like transmission of protein aggregates in neurodegeneration

  2025cites this paper
• Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.

  2025cites this paper
• β-Amyloid induces microglial expression of GPC4 and APOE leading to increased neuronal tau pathology and toxicity

  2025cites this paper
• Intercellular communication via exosomes: A new paradigm in the pathophysiology of neurodegenerative disorders.

  2025cites this paper
• Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease

  2025cites this paper
• Regulatory Roles of Exosomes in Aging and Aging-Related Diseases

  2025cites this paper
• Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy

  2025cites this paper
• The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease.

  2025cites this paper
• Neuronal guidance signaling in neurodegenerative diseases: Key regulators that function at neuron-glia and neuroimmune interfaces

  2025cites this paper
• Evaluation of [18F]JNJ-CSF1R-1 as a Positron Emission Tomography Ligand Targeting Colony-Stimulating Factor 1 Receptor

  2025cites this paper
• Cytotoxicity of Amyloid β1–42 Fibrils to Brain Immune Cells

  2025cites this paper
• Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.

  2025cites this paper
• Diverse influences on tau aggregation and implications for disease progression

  2025cites this paper
• Chronic alcohol exposure during young adulthood attenuates microglial reactivity and downstream immune response pathways in a mouse model of tauopathy later in life.

  2025cites this paper
• Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity

  2025cites this paper
• Excessive Alcohol Use as a Risk Factor for Alzheimer's Disease: Epidemiological and Preclinical Evidence.

  2025cites this paper
• Extracellular particles: emerging insights into central nervous system diseases

  2025cites this paper
• Mechanism of Tau Protein Incorporation into Exosomes via Cooperative Recognition of KFERQ-like Motifs by LAMP2A and HSP70.

  2025cites this paper
• Distinct factors drive the progression of tau pathology in Alzheimer's disease

  2025cites this paper
• A mouse model of early sporadic tau pathology induces neurogenic plasticity in the hippocampus

  2025cites this paper
• Dual Role of Exosomes in Parkinson's Disease: Adenine Exerts a Beneficial Effect

  2025cites this paper
• The Role of Microglial Exosomes in Clozapine Treatment: Effect on Cognition in Schizophrenia

  2025cites this paper
• What Information do Systemic Pathological Changes Bring to the Diagnosis and Treatment of Alzheimer’s Disease?

  2025cites this paper
• BIN1 and Alzheimer's disease: the tau connection.

  2025cites this paper
• Neurodegeneration and the immune system: lessons from autoimmune encephalitis

  2025cites this paper
• Microglia-derived sEV: Friend or foe in the pathogenesis of cognitive impairment.

  2025cites this paper
• Regulation of synaptic mitochondria by extracellular vesicles and its implications for neuronal metabolism and synaptic plasticity

  2025cites this paper
• Are we missing a trick by not exploiting fruit flies in inflammation-led drug discovery for neurodegeneration?

  2025cites this paper
• Physical confinement and phagocytic uptake induce directional migration

  2025cites this paper
• Chromogranin A deficiency attenuates tauopathy by altering epinephrine–alpha-adrenergic receptor signaling in PS19 mice

  2025cites this paper
• Knockdown of OPTN modulates miRNA-125b-5p expression via NF-κB pathways in amyotrophic lateral sclerosis.

  2025cites this paper
• Microglial Regulation of Neural Networks in Neuropsychiatric Disorders

  2025cites this paper